1. WHO Consultation on Obesity.

Obesity : preventing and managing the global epi

demic : report of a WHO consultation. Geneva, 1997.
2. World Health Organization. Obesity and overweight. 2015. Available from: http
://www.who.int/mediacentre/factsheets/fs311/. Cited 30 September, 2016.
3. Apovian CM. The Obesity Epidemic--Understanding the Disease and the Treatment
. N Engl J Med. 2016 Jan 14;374(2):177-9.
4. World Health Organization. Definition, diagnosis and classification of diabet
es mellitus and its complications. Part 1: Diagnosis and classification of diabe
tes mellitus. Geneva, 1999.
5. World Health Organization. Diabetes. 2015. http://www.who.int/mediacentre/fac
tsheets/fs312/en/. Cited 30 September, 2016.
6. World Health Organization. Global report on diabetes. Geneva, 2016.
7. Murgua-Romero M, Jimnez-Flores JR, Sigrist-Flores SC, Tapia-Pancardo DC, JimnezRamos A, Mndez-Cruz AR, Villalobos-Molina R. Prevalence of metabolic syndrome in
young Mexicans: a sensitivity analysis on its components. Nutr Hosp. 2015 Jul 28
;32(1):189-95.
8. Rojas Martnez, Mara Rosalba, et al, Epidemiologa de la diabetes mellitus en Mxico ,
en Aguilar Salinas, Carlos A. et al, (eds),Acciones para enfrentar a la diabetes
. Documento de postura. Academia Nacional de Medicina de Mxico, Mxico, 2015.
9. Maiz C, Alvarado J, Quezada N, Salinas J, Funke R, Boza C.Bariatric surgery i
n 1119 patients with preoperative body mass index<35 (kg/m(2)): results at 1 yea
r.Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1127-32.
10. Mller-Stich BP, et al. Surgical versus medical treatment of type 2 diabetes m
ellitus in nonseverely obese patients: a systematic review and meta-analysis. An
n Surg 2015;261:421 429.
11. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughl
in S, et al. How do we define cure of diabetes?. Diabetes Care. 2009 Nov;32(11):
2133-5.
12. Malin SK, Bena J, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, et
al. Attenuated improvements in adiponectin and fat loss characterize type 2 diab
etes non-remission status after bariatric surgery.Diabetes Obes Metab. 2014 Dec;
16(12):1230-8.
13. Fellici AC, Lambert G, Lima MM, Pareja JC, Rodovalho S, Chaim EA, Geloneze B
. Surgical treatment of type 2 diabetes in subjects with mild obesity: mechanism
s underlying metabolic improvements. Obes Surg. 2015 Jan;25(1):36-44.).

Booth A, Magnuson A, Fouts J, Foster M. Adipose tissue, obesity and adipokines:

role in cancer promotion.Horm Mol Biol Clin Investig. 2015 Jan;21(1):57-74.
Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, McLaughlin S
, et al. How do we define cure of diabetes?. Diabetes Care. 2009 Nov;32(11):2133
-5.
Fellici AC, Lambert G, Lima MM, Pareja JC, Rodovalho S, Chaim EA, Geloneze B. Su
rgical treatment of type 2 diabetes in subjects with mild obesity: mechanisms un
derlying metabolic improvements. Obes Surg. 2015 Jan;25(1):36-44.).
Garten A, Schuster S, Penke M, Gorski T, de Giorgis T, Kiess W. Physiological an
d pathophysiological roles of NAMPT and NAD metabolism.Nat Rev Endocrinol. 2015
Sep;11(9):535-46.
Horwitz D, et al. Three-year follow-up comparing metabolic surgery versus medica
l weight management in patients with type 2 diabetes and BMI 30-35. The role of
sRAGE biomarker as predictor of satisfactory outcomes. Surg Obes Relat Dis. 2016
Jan 21.
Maiz C, Alvarado J, Quezada N, Salinas J, Funke R, Boza C.Bariatric surgery in 1
119 patients with preoperative body mass index<35 (kg/m(2)): results at 1 year.S
urg Obes Relat Dis. 2015 Sep-Oct;11(5):1127-32.
Malin SK, Bena J, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, et al.
Attenuated improvements in adiponectin and fat loss characterize type 2 diabetes
non-remission status after bariatric surgery.Diabetes Obes Metab. 2014 Dec;16(1

2):1230-8.
Mller-Stich BP, et al. Surgical versus medical treatment of type 2 diabetes melli
tus in nonseverely obese patients: a systematic review and meta-analysis. Ann Su
rg 2015;261:421 429.
Murgua-Romero M, Jimnez-Flores JR, Sigrist-Flores SC, Tapia-Pancardo DC, Jimnezos A, Mndez-Cruz AR, Villalobos-Molina R. Prevalence of metabolic syndrome in you
ng Mexicans: a sensitivity analysis on its components. Nutr Hosp. 2015 Jul 28;32
(1):189-95.
Park SE, Park CY, Sweeney G.. Biomarkers of insulin sensitivity and insulin resi
stance: Past, present and future. Crit Rev Clin Lab Sci. 2015;52(4):180-90.
9. Ionut V, Burch M, Youdim A, Bergman RN. Gastrointestinal
hormones and bariatric surgery-induced weight loss. Obesity
(Silver Spring) 2013;21:1093-103.